SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

Dealing with staff addicts in the workplace New York radiologist allegedly wrote 280 illegal prescriptions

MWA 2015: Assessing the risk of pandemics and the promise of 3-D printing The show kicks off in ten days. What can visitors expect?

Illinois Health and Science to acquire IBA Molecular North America, Inc. IBAM NA will work with Zevacor to produce radionuclides

Mallinckrodt acquires Ikaria for $2.3 billion Deal expands their neonatal critical care footprint

Study calls whole-body MRI ‘promising’ for enthesitis A recently published study calls whole body magnetic resonance imaging (wbMRI) a “promising” new imaging modality for evaluating enthesitis in patients with psoriatic arthritis and axial spondyloarthritis.

Major amyloid imaging trial launched by ACR, Alzheimer’s Association The American College of Radiology and the Alzheimer's Association have launched a new four-year study on beta-amyloid imaging in diagnosing and treating Alzheimer’s and other dementias

Thousands of NYC RNs picket, claim 'staffing levels not safe' They will converge in Albany next week to lobby for legislation

HIMSS 2015: Cloud data puts health care on cyber risk frontline Hackers were on the mind of many attendees this year

CMS changes to Meaningful Use program mostly welcome A proposed rule released Friday by the Centers for Medicare and Medicaid Services (CMS) aims to make it easier for hospitals and physician practices to achieve meaningful use of electronic health records

HIMSS 2015: Three big data innovators you need to know Breakthrough analytical insights for unexpected market segments

ASTRO 2012: Antidepressant 'rinse' could relieve RT mouth pain

by Brendon Nafziger , DOTmed News Associate Editor
Patients with head and neck cancers who receive radiation therapy often develop painful mouth and throat sores. But an antidepressant mouth rinse might help make the pain more bearable, according to a study presented Monday at ASTRO 2012 in Boston.

The double-blind, phase 3 randomized control trial found a mouthwash made of Doxepin, a tricyclic antidepressant, outperformed a placebo rinse in relieving pain from oral mucositis. Also, two-thirds of patients who tried the Doxeprin wash found it helpful enough to ask for a prescription for it.

Story Continues Below Advertisement

We want to buy your Siemens Symphony or Avanto MRI -- today!

Top Dollar Paid, Fixed or Mobile. Call our Siemens Specialist for a Quote today -- 212-558-6600 Ext. 250 DOTmed Certified



"We think it can be used in addition to other (pain relief) agents at this point," study author Dr. Robert C. Miller, a radiation oncologist with Mayo Clinic in Rochester, Minn., told reporters during a press conference Monday. "It's not going to get rid of narcotics, but hopefully it will help people take less."

Doxepin goes by the brand names Adapin, Silenor and Sinequan.

The study, which took place in 26 institutions and involved 155 patients, followed patients for about four hours after receiving their first round of radiation and either a placebo or the Doxepin rinse. For their next fraction, the patients were crossed over to the other rinse.

According to Miller, patients just swishing around a placebo rinse, which was basically just water, experienced pain relief: pain went down an average of 1 point on a 10-point scale. With Doxepin, pain went down about 2 points on average, for a statistically significant difference, he said.

When asked whether they'd like to continue with the Doxepin rinse, 64 percent asked for a prescription, he said.

The Doxepin rinse had no serious side effects, but it did have some mild ones, such as a temporary burning sensation or unpleasant taste. Between 10 and 40 percent of people also experienced drowsiness after using it, and Miller said many patients preferred to take it at night, to help them sleep.

"Compared to placebo, we think Doxepin is an effective agent to reduce pain from oral mucositis," he said.

He also said the drug might be useful in other areas besides oral mucositis pain control - such as for people with nasty canker sores.

The study, "N09C6 (Alliance) - A Phase III, Randomized Double-Blind Study of Doxepin Rinse versus Placebo in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Head and Neck Radiotherapy with or without Chemotherapy," was part of a series given at ASTRO on patient outcomes and perspectives on radiation treatment. It was conducted with the Alliance for Clinical Trials in Oncology.

Back to DOTmed News
  Pages: 1

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Central
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED